All the participants who received the half dose followed by a full dose were under 55
By Ross Clark
If one vaccine provides immunity lasting months and another years, the relative costs of each could shift dramatically
By Ross Clark
Over 50 million cases of COVID-19 have now been recorded globally — and yet only a handful of cases of reinfection have been documented
By Ross Clark
A new paper looks at the possibility that SARS-CoV-2 was artificially created
By Ross Clark
The company can provisionally claim that their vaccine is 94.5 percent effective
By Ross Clark
The estimated number of deaths globally from measles climbed to 207,500 in 2019
By Ross Clark
Any vaccine that proves partly effective will be welcomed with open arms by a world which largely remains in lockdown or semi-lockdown
By Ross Clark
If antibodies were our only defense, surely we would be seeing vast numbers of reinfections?
By Ross Clark
No one is telling Americans to ‘look at the EU’ anymore
By Ross Clark
A Stanford professor has produced perhaps the most comprehensive attempt to estimate the infection fatality rate
By Ross Clark
A team at the University of Nevada has been studying him
By Ross Clark
It was therapeutic drugs that in the end made HIV less deadly
By Ross Clark
Several studies bring into question a central assumption of the global response to COVID-19
By Ross Clark
New cases are now declining in Germany, and Sweden, and remaining flat in Italy, Ireland and Belgium
By Ross Clark
Are we fearing a ‘second wave’ which our immune systems already have well in hand?
By Ross Clark
